<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05104970</url>
  </required_header>
  <id_info>
    <org_study_id>SunnyD</org_study_id>
    <nct_id>NCT05104970</nct_id>
  </id_info>
  <brief_title>Evaluation of Cholecalciferol Therapy in Alleviating Body Aches and Pains During Pregnancy</brief_title>
  <acronym>PRECIOUS</acronym>
  <official_title>Evaluation of Cholecalciferol Therapy in Alleviating Body Acheds and Pains During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scotmann Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rawalpindi Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Scotmann Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to adapt the gold standard of research and adapt a randomized&#xD;
      placebo-controlled trial to evaluate the efficacy of vitamin D in alleviating chronic body&#xD;
      aches and pains during pregnancy.and to explore the comparative bio availability and clinical&#xD;
      efficacy of the two most commonly used forms of Cholecalciferol i.e ampoules and softgel&#xD;
      capsules.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D is a hormone synthesized in the skin in the presence of sunlight.Like other&#xD;
      hormones,vitamin D plays a role in a wide range of processes in the body.This trial aims to&#xD;
      review the possible role of vitamin D in nociceptive and inflammatory pain.In observational&#xD;
      studies,low vitamin D levels have been associated with increased pain and higher opioid&#xD;
      doses.Recent interventional studies have shown promising effects of vitamin D supplementation&#xD;
      on cancer pain and muscular pain.Possible mechanisms for vitamin D in pain management are the&#xD;
      anti-inflammatory effects mediated by reduced cytokine and prostaglandin E2(PGE2)is&#xD;
      especially interesting and exhibits a credible mechanistic explanation.Studies have shown the&#xD;
      increased prevalence of Vitamin D in pregnancy,which might lead to increased muscular aches&#xD;
      and pains.Therefore,this study aims to evaluate the role of Vitamin D in alleviating chronic&#xD;
      aches and pains during pregnancy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale for pain (VAS)</measure>
    <time_frame>3 months</time_frame>
    <description>Using a ruler, the score is determined by mea-suring the distance (mm) on the 10-cm line between the &quot;no pain&quot; anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.&#xD;
SunnyD10000 IU softgel capsule</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum level of 25(OH)D</measure>
    <time_frame>3 months</time_frame>
    <description>Most experts agree that 25(OH)D of &lt; 20 ng/ml is considered to be vitamin D deficiency whereas a 25(OH)D of 21-29 ng/ml is considered to be insufficient. The goal should be to maintain both children and adults at a level &gt; 30 ng/ml to take full advantage of all the health benefits that vitamin D provides.&#xD;
SunnyD10000 IU softgel capsule</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>SunnyD 5000 IU softgel capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cholecalciferol 5000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SunnyD 10000 IU softgel capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cholecalciferol 10000 IU</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Softgel capsule</description>
    <arm_group_label>SunnyD 5000 IU softgel capsule</arm_group_label>
    <other_name>SunnyD 5000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Softgel capsule</description>
    <arm_group_label>SunnyD 10000 IU softgel capsule</arm_group_label>
    <other_name>SunnyD 10000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant women (20-24 weeks of gestation)&#xD;
&#xD;
          2. Age 20-40&#xD;
&#xD;
          3. Presence of body aches and pain falling in the pain chart defined&#xD;
&#xD;
          4. Vitamin D deficiency (serum 25(OH)D &lt; 20 ng/ml)&#xD;
&#xD;
          5. Resident of Rawalpindi, Islamabad for easy follow up throughout the study period (3&#xD;
             months per participant)&#xD;
&#xD;
          6. Willingness and availability to show-up in the follow up visits and serum testing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &lt;20 weeks gestation&#xD;
&#xD;
          2. &gt;24 weeks of gestation&#xD;
&#xD;
          3. Acute sharp pain&#xD;
&#xD;
          4. Presence of co-morbidities (gestational diabetes, Pregnancy Induced Hypertension,&#xD;
             Anemia Hb &lt;10.5)&#xD;
&#xD;
          5. Vitamin D sufficiency or moderate deficiency (serum 25(OH)D &gt; 20 ng/ml)&#xD;
&#xD;
          6. Distant residents difficult to call for a follow&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women (20-24 weeks of gestation)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad Umar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rawalpindi Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shazia Syed</last_name>
    <phone>00923335426868</phone>
    <email>lonsa25@student.london.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sadia Khan</last_name>
    <phone>00923215842365</phone>
    <email>docsadiakhan@gmail.com</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Proforma</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

